parthenolide has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Liu, Q; Wang, W | 1 |
| Bahabadi, M; Goudarzi, F; Hashemnia, M; Karimi, J; Khodadadi, I; Mohammadalipour, A; Sheikh, N; Solgi, G | 1 |
2 other study(ies) available for parthenolide and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway.
Topics: Animals; Disease Models, Animal; Fibrosis; Hippo Signaling Pathway; Inflammation; Lipid Metabolism; Male; Metabolic Diseases; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Protein Serine-Threonine Kinases; Sesquiterpenes; Signal Transduction | 2021 |
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Liver; Male; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase; Triglycerides; Tumor Necrosis Factor-alpha | 2017 |